SOFTWAVE® TISSUE REGENERATION TECHNOLOGIES: Receives FDA Clearance for the Treatment of Burn Wounds
SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, was cleared by the FDA on Friday, Aug. 28, 2020, for the treatment of superficial, partial-thickness, second-degree burns in adults (FDA 510k letter number K200926).